Semler Scientific, which was issued and is now listed on Nasdaq, is a medical technology company that actively seeks new and uncharted territories to invest their resources into. This has already been demonstrated by an uncharacteristic buyout of 111 bitcoins to the tune of an additional 10 million USD. This latest purchase, spanning from February 14 to April 24, 2025, marks the company’s views on never backing out of infinity.
Best of Buying Bitcoin: A Wise Plan
In a strategic expenditure of resources, the company purchased their latest batch of coins at a staggering 90,124 USD, coming from excess capital made available through the company’s ATM offering plans. In all likelihood, the overall Bitcoin Semler Scientific now holds surpasses 3,303. The compulsive craze at which the company is buying this blockchain property only suggests a matter of time before the price exceeds 1 billion USD. And sooner or later become Semler Scientific’s greatest line of assets earning.
As of April 24, the total approximate worth of the assets stood at roughly Semler Scientific’s 309.1 million USD evaluation, showing the level of sustenance of value despite the dense rate of inflation in the assets value. Furthermore, continually holding a steady Bitcoin valuation strengthens the perception, belief, and reliance on the gold standard equivocal currency, hinting at Buddha’s monetary policies.
Betting on Crypto: Mixed-Securities Offering
Semler Scientific’s Bitcoin acquisition adopted a different scope with the recent filing of a $500 million mixed-securities offering, which allows the company to repeatedly auction different classes of securities, such as bonds, common stock, and units of undivided ownership interest, with the principal goal of using revenues to further boost its Bitcoin reserve.
This bold financial move also serves as an indication of crystal synergy between the company’s treasury management system and the volatile crypto market.
In order to effectuate purchases of Bitcoin, Semler Scientific has a distinct Controlled Equity Offering Sales Agreement. Under the prior agreement with Cantor Fitzgerald, the firm underwent an initial public offering where it issued and sold 2,438,274 shares and accrued net proceeds of roughly $126 million. After activating an ATM equity offering program on April 22, 2025, the company stopped share distribution under the prior agreement and moved to a new agreement with Barclays Capital, Cantor Fitzgerald, Canaccord Genuity LLC, and three additional firms.
The new agreement enables Semler Scientific to issue and sell common stock of up to $500 million, of which 57,100 have been sold by the 24th of April, yielding net proceeds of roughly $2 million.
Bitcoin Yield as a Key Performance Indicator
Semler Scientific considers Bitcoin yield as one of the most crucial. Semler Scientific has identified this KPI as instrumental for assessing if the company should proceed with its digital asset acquisition strategy. As of April 24, 2025, the company registered an astonishing 23.5% year-to-date BTC yield. This figure is meant to measure the value of Bitcoin investments relative to stockholder value in this case, the rationale concerning the provision of additional shares or convertible securities for the company’s assets.
A Bold Strategy: Bridging MedTech and Crypto
Semler Scientific continues and refreshingly holds a position in Bitcoin. This traditional, sedate stance is highly uncharacteristic of a medical technology firm. Bitcoin yield serves a strategic objective. To those wishing to understand its financial logic, the firm poses full and open attention, clearly stating its strategy. Such a decisive engagement demonstrates the blurring of the boundaries of the aging realm and of the emerging novel assets.
